The IASLC Lung Cancer Staging Project: Proposals for the Revision of the M Descriptors in the Forthcoming 9th edition of the TNM Classification of Lung Cancer.

Lung cancer Metastases Non–small cell lung cancer stage IV lung cancer stage classification

Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235

Informations de publication

Date de publication:
04 Feb 2024
Historique:
received: 08 11 2023
revised: 24 01 2024
accepted: 31 01 2024
medline: 7 2 2024
pubmed: 7 2 2024
entrez: 6 2 2024
Statut: aheadofprint

Résumé

This study analyzed all metastatic categories of the current tumor, node, and metastasis (TNM) classification of non-small cell lung cancer to propose modifications of the M component in the next edition (9 A database of 124,581 patients diagnosed between 2011 and 2019 was established; of these, 14,937 with NSCLC in stage IVA-IVB were available for this analysis. Overall survival was calculated using the Kaplan-Meier method, and prognosis assessed using multivariable-adjusted Cox proportional hazards regression. The 8 These data validate the 8

Identifiants

DOI: 10.1016/j.jtho.2024.01.019 PMID: 38320664
pubmed: 38320664
pii: S1556-0864(24)00060-1
doi: 10.1016/j.jtho.2024.01.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Auteurs

Kwun M Fong (KM)

Department of Thoracic Medicine, The Prince Charles Hospital, University of Queensland Thoracic Research Centre, Brisbane, Australia. Electronic address: kwun.fong@health.qld.gov.au.

Adam Rosenthal (A)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Dorothy J Giroux (DJ)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Katherine K Nishimura (KK)

Cancer Research And Biostatistics (CRAB), Seattle, Washington.

Jeremy Erasmus (J)

Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Yolande Lievens (Y)

Department of Radiation Oncology, Ghent University Hospital and Ghent University, Gent, Belgium.

Mirella Marino (M)

Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Edith M Marom (EM)

Department of Diagnostic Imaging, Chaim Sheba Medical Center, Tel-Aviv University, Ramat Gan, Israel.

Paul Martin Putora (PM)

Department of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland and Department of Radiation Oncology, Inselspital, Bern University Hospital and University of Bern, Switzerland.

Navneet Singh (N)

Lung Cancer Clinic, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Francisco Suárez (F)

Department of Thoracic Surgery, Clínica Santa María, Universidad de Los Andes, Santiago, Chile.

Ramon Rami-Porta (R)

Department of Thoracic Surgery, Hospital Universitari Mutua Terrassa, University of Barcelona,Terrassa, Barcelona, Spain; and Network of Centres for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Barcelona, Spain.

Frank Detterbeck (F)

Department of Surgery, Division of Thoracic Surgery, Yale University School of Medicine, New Haven, CT.

Wilfried Ee Eberhardt (WE)

Department of Medical Oncology, West German Cancer Center, University Medicine Essen and Ruhrlandklinik, University Duisburg-Essen.

Hisao Asamura (H)

Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan.

Classifications MeSH